ArticleScientific reports2025
Microbiological risk assessment during the procurement and processing of cells, tissues and breast milk using the MiRCA tool.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The Microbiological Risk Classification and Assessment tool (MiRCA) is a valuable instrument elaborated by the European Directorate for the Quality of Medicines & HealthCare (EDQM) for evaluation of the microbiological risks associated with the procurement, processing, testing, storage and distribution of substances of human origin (SoHO). Own data of critical points in the procurement and processing of SoHO were put into the MiRCA, including the percentage of microbiological contamination before and after processing. These data were extracted from retrospective studies performed with different types of SoHO products prepared in the Tissue Bank and the Human Milk Bank of the University Hospital Hradec Králové. The result of the analysis was a final risk number calculated separately for the procurement and processing of each type of SoHO, and the overall risk value and its probability. A total of 7,881 SoHO products were analysed. For solid tissues, the lowest risk value was determined during the procurement and processing of femoral heads (total risk value 14.4 of 695 possible). Cell collection and processing revealed higher risk values (total risk values ranging from 150 to 161 of 695 possible). The greatest risk of microbial contamination was observed in breast milk processing (172.5 of 695 possible), where the percentage of post-processing microbiological findings was 11.6%. We conclude that the MiRCA is a valuable tool for conducting microbiological risk assessments for procurement, processing, testing, and distribution of SoHO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.